Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...
HOUSTON, TX (December 8, 2021) – The Texas Heart Institute Biorepository is proud to announce its third reaccreditation by the...
THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
HOUSTON, TX – June 2021 – Drs. Kirstin Matthews (Baker Institute) and Emerson Perin (THI) spearhead a joint research and...
Texas Heart Institute director of Regenerative Medicine Research and director of the Center for Cell and Organ Biotechnology, Dr. Doris A....
HOUSTON – (Sept. 25, 2019) – A group of researchers at the Texas Heart Institute, Baylor College of Medicine and the...
Researchers in the Texas Heart Institute’s Cardiomyocyte Renewal Laboratory are a step closer to possibly restoring the regenerative properties of...
In 2017, Texas passed House Bill 810, also known as “Charlie’s Law,” which expanded patient access to experimental stem cell...
The THI International Symposium on Cardiovascular Regenerative Medicine welcomes physicians, surgeons and scientists from around the world who are leading cardiovascular regenerative...
Visit U.S. News & World Report
